ReP USP - Resultado da busca

Filtros : "FIBROSE PULMONAR (TERAPIA)" Removido: "Wells, Athol U." Limpar

Filtros

Artigo de periodico
Angiotensin II type 1 and 2 receptors and lymphatic vessels modulate lung remodeling and fibrosis in systemic sclerosis and idiopathic pulmonary fibrosis (2014)
Parra, Edwin Roger; Ruppert, Aline Domingos Pinto; Capelozzi, Vera Luiza
Source: Clinics. Unidade: FM
Subjects: ANGIOTENSINA II, SOBREVIDA, FIBROSE PULMONAR (TERAPIA), FÁRMACOS (SISTEMA CARDIOVASCULAR)
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PARRA, Edwin Roger e RUPPERT, Aline Domingos Pinto e CAPELOZZI, Vera Luiza. Angiotensin II type 1 and 2 receptors and lymphatic vessels modulate lung remodeling and fibrosis in systemic sclerosis and idiopathic pulmonary fibrosis. Clinics, v. 69, n. 1, p. 47-54, 2014Tradução . . Disponível em: https://doi.org/10.6061/clinics/2014(01)07. Acesso em: 03 nov. 2024.
APA
Parra, E. R., Ruppert, A. D. P., & Capelozzi, V. L. (2014). Angiotensin II type 1 and 2 receptors and lymphatic vessels modulate lung remodeling and fibrosis in systemic sclerosis and idiopathic pulmonary fibrosis. Clinics, 69( 1), 47-54. doi:10.6061/clinics/2014(01)07
NLM
Parra ER, Ruppert ADP, Capelozzi VL. Angiotensin II type 1 and 2 receptors and lymphatic vessels modulate lung remodeling and fibrosis in systemic sclerosis and idiopathic pulmonary fibrosis [Internet]. Clinics. 2014 ; 69( 1): 47-54.[citado 2024 nov. 03 ] Available from: https://doi.org/10.6061/clinics/2014(01)07
Vancouver
Parra ER, Ruppert ADP, Capelozzi VL. Angiotensin II type 1 and 2 receptors and lymphatic vessels modulate lung remodeling and fibrosis in systemic sclerosis and idiopathic pulmonary fibrosis [Internet]. Clinics. 2014 ; 69( 1): 47-54.[citado 2024 nov. 03 ] Available from: https://doi.org/10.6061/clinics/2014(01)07
Trabalho de evento-resumo periodico
Effect of bone marrow-derived cells in bleomycin-induced lung fibrosis (2007)
Rizzatti, F. G.; Ramos, S. G.; Pádua, A. I.; Voltarelli, Júlio César; Rego, Eduardo Magalhães; Floriano, E. M.; Martinez, José Antônio Baddini
Source: American Journal of Respiratory and Critical Care Medicine. Conference titles: International Conference of The American Thoracic Society. Unidade: FMRP
Assunto: FIBROSE PULMONAR (TERAPIA)
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
RIZZATTI, F. G. et al. Effect of bone marrow-derived cells in bleomycin-induced lung fibrosis. American Journal of Respiratory and Critical Care Medicine. New York: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. . Acesso em: 03 nov. 2024. , 2007
APA
Rizzatti, F. G., Ramos, S. G., Pádua, A. I., Voltarelli, J. C., Rego, E. M., Floriano, E. M., & Martinez, J. A. B. (2007). Effect of bone marrow-derived cells in bleomycin-induced lung fibrosis. American Journal of Respiratory and Critical Care Medicine. New York: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo.
NLM
Rizzatti FG, Ramos SG, Pádua AI, Voltarelli JC, Rego EM, Floriano EM, Martinez JAB. Effect of bone marrow-derived cells in bleomycin-induced lung fibrosis. American Journal of Respiratory and Critical Care Medicine. 2007 ; 175 A736.[citado 2024 nov. 03 ]
Vancouver
Rizzatti FG, Ramos SG, Pádua AI, Voltarelli JC, Rego EM, Floriano EM, Martinez JAB. Effect of bone marrow-derived cells in bleomycin-induced lung fibrosis. American Journal of Respiratory and Critical Care Medicine. 2007 ; 175 A736.[citado 2024 nov. 03 ]

Digital Library of Intellectual Production of Universidade de São Paulo 2012 - 2024